McKesson Reaches $150 Million Settlement With Justice Department and DEA
McKesson will pay the U.S. government $150 million to settle allegations that it failed to properly oversee shipments of drugs, including opioid painkillers, between 2008 and 2013, federal agencies said. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 18, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Biogen Reaches Settlement and License Agreement for MS Drug
Biogen has reached a settlement and license agreement with Forward Pharma for its best-selling multiple sclerosis drug ahead of the completion of a patent-interference case. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 17, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
UnitedHealth's Revenue, Profit Tops Forecasts
UnitedHealth Group Inc. reported a 56% increase in profit in the latest quarter, with results fueled by growth in its core insurance unit and its Optum health-services arm, as well as reduced impact from its money-losing Affordable Care Act business. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 17, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Two Reports Challenge GOP Criticism of Health-Care Law
The jump in premiums on the health law ’s exchanges was a one-time correction, and a brisk pace of sign-ups shows the marketplaces are on solid ground, the Obama administration said. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 11, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Valeant Agrees to Sell Dendreon to Sanpower for $820 Million
Valeant Pharmaceuticals Inc. agreed to sell its Dendreon cancer business to Chinese conglomerate Sanpower for $820 million, part of an effort by the beleaguered drugmaker to unload assets and pare debt. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Johnson & Johnson to Report Average U.S. Price Increases
Johnson& Johnson is planning to issue a report next month outlining how much it has raised the U.S. prices of its prescription drugs, the latest pharmaceutical company effort to address intense public concern about the cost of medicines. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 10, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Trump Pressures Republicans to Repeal, Replace Health Law at Same Time
President-elect Donald Trump is increasing pressure on congressional Republicans to vote at the same time to both repeal and replace the Affordable Care Act, but party leaders haven ’t indicated any shift in strategy to make that happen. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
UnitedHealth to Acquire Surgical Care Affiliates for $2.3 Billion
UnitedHealth Group Inc. ’s Optum health-services arm has agreed to acquire Surgical Care Affiliates Inc. for about $2.3 billion, adding a major surgical company to its growing roster of doctor groups and clinics. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 9, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Parkinson's Therapy Gets Fresh Look From Device Makers
Medtronic is facing new competition in supplying devices for deep brain stimulation, an established therapy for moderating the symptoms of Parkinson ’s disease. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 9, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Merrimack to Sell Onivyde, Generic Doxil to Ipsen
Merrimack Pharmaceuticals has agreed to sell some of its oncology assets, including the pancreatic cancer drug Onivyde, to French drug maker Ipsen. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 9, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Biotech Starts Year With a Look Ahead
In biotech, it is how you start the year that counts. Investors will get a good look at how 2017 is shaping up starting Monday when the 35th annual J.P. Morgan Healthcare Conference kicks off in San Francisco. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 9, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Alexion Says Management Improperly Pressured Staff to Boost Sales
Alexion Pharmaceuticals said Wednesday that senior management pressured staff to get customers to order its flagship drug earlier than needed to meet financial targets. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 5, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Gates Foundation to Invest Up to $140 Million in HIV-Prevention Device
The Bill& Melinda Gates Foundation is investing as much as $140 million to support development of a tiny implantable drug pump it believes could help prevent people in sub-Saharan Africa and elsewhere from becoming infected with HIV, the virus that causes AIDS. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 29, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Seattle Genetics Cancer-Drug Trials on Hold After Four Patient Deaths
Seattle Genetics Inc. said the U.S. Food and Drug Administration had placed several of its early-stage cancer drug trials on hold after four patients died during treatment. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 29, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Denies Amphastar's New Primatene Mist Inhaler
Amphastar Pharmaceuticals Inc. said Tuesday that the U.S. Food and Drug Administration had denied its new drug application for its over-the-counter Primatene Mist asthma inhaler. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 29, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
